Ompenaclid drug page Clinical trials

Trials with Ompenaclid

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
4Countries
159Planned patients

Showing 1–1 of 1

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
Finished Phase 1 89 patients NCT03597581

This is a Phase 1 study currently evaluating PO administered ompenaclid in combination with FOLFIRI and bevacizumab in patients with advanced (i.e., locally advanced and unresectable, or metastatic) previously treated colorectal adenocarci…

United States Jun 2018 – Mar 2025 Interventional